Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Nature Communications volume 12, Article number: 3309 (2021)
Hirofumi Ohashi et al, Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment, iScience (2021). DOI: 10.1016/j.isci.2021.102367
Daniloski, Z., Jordan, T.X., Wessels, H.-H., Hoagland, D.A., Kasela, S., Legut,
M., Maniatis, S., Mimitou, E.P., Lu, L., Geller, E., Danziger, O., Rosenberg, B.R., Phatnani, H., Smibert, P., Lappalainen, T., tenOever, B.R., Sanjana, N.E., Identification of required host factors for SARSCoV-2 infection in human cells, Cell (2020), doi: https://doi.org/10.1016/j.cell.2020.10.030.
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein, Robert A. BrodskyBlood blood.2020008248.https://doi.org/10.1182/blood.2020008248
July 24, 2020 Nature